Cellular immunity mediated by T cells plays a major role in protection against intracellular infections, including leprosy, a chronic disease caused by Mycobacterium leprae. In this work, we describe CD4+ T-cell clones, isolated from healthy humans immunized with M. leprae, which recognize a novel M. leprae protein antigen previously isolated from a Agtll DNA expression library. On the basis of the deduced primary structure of the carboxyl-terminal part of the antigen, we have used a synthetic-peptide approach to exactly define the T-cell epitope recognized. Importantly, major histocompatibility complex restriction studies showed that the epitope is presented by an HIA-DRw53 molecule which is frequently expressed in many populations.
In leprosy, both protective immunity and immunopathology are dependent on antigen-specific major histocompatibility complex (MHC) class II-restricted T-cell responses (6, 33) . Identification and characterization of Mycobacterium leprae protein antigens with regard to epitopes and MHC restriction elements used in T-cell recognition are therefore essential to understand the pathological conditions associated with the disease and design subunit vaccines to induce prophylaxis.
In general, subunit vaccine candidates based on cell-mediated immunity should consist of epitopes presented to T cells by HLA molecules frequently expressed in the population to be protected and capable of inducing long-lasting T-cell memory including the relevant effector functions. With regard to leprosy, a subunit vaccine approach seems necessary because of both the limited supply of M. leprae and the possible presence of suppressor epitopes (7) .
By screening mycobacterial recombinant antigens, selected mainly from Xgtll recombinant DNA expression libraries (46, 47) , a variety of different protein antigens relevant to cellmediated immunity have been identified and characterized (8, 13, 14, 16, 17, 20, 23, 25, 26, 29) . Some of these protein antigens, mostly heat shock proteins (HSP), have been extensively mapped with respect to primary structure of T-cell epitopes and identification of the respective MHC elements restricting the response (4, 12, 15, 28, 30, 31, 33, 43) . However, the MHC restriction of these T-cell epitopes follows the general rule in the sense that only one specific HLA molecule with a limited frequency in the relevant populations is able to present a given peptide to the responding T cells. In (36) . Subcloning into Xgtl 1 of the DNA coding for M. leprae part of the fusion protein from the recombinant phage 13B3 was performed by standard methods (36) . The amino acid sequence of the M. leprae part of the fusion protein was deduced from the DNA sequence of the subclone.
Synthetic peptides. Three peptides P1, P2, and P3, covering the amino acid sequence of the M. leprae part of the fusion protein expressed from the recombinant phage 13B3, were synthesized by using the Du Pont RaMPS system and fluorenylmethoxycarbonyl (Fmoc) chemistry (5) . These peptides were 17-mers and overlapped with the neighboring peptide by S amino acids (aa). Another series of 30 peptides corresponding to the M. leprae DNA in the subclone were synthesized by the Pepscan method (41) . These peptides were 12-mers and represented jumps of 1 aa along the sequence. The M. leprae 18-kDa HSP peptide (designated 38-50) was synthesized and used as described earlier (31) .
APC. Heparinized venous blood was obtained from the M. leprae-vaccinated subjects (9) (24) . To establish the T-cell lines, two million PBMC in 1 ml of complete medium (RPMI 1640 plus 10% AB serum and 1% penicillin-streptomycin) were cultured with M. leprae (5 x 107 bacilli per ml) or M. bovis BCG (wet weight, 10 ,ug/ml) in the wells of 24-well Costar plates (Costar, Cambridge, Mass.). The plates were incubated at 37°C in an atmosphere of 5% CO2 and 95% air. After 6 days of incubation, 100 U of recombinant interleukin-2 (Amersham, Amersham, United Kingdom) was added to the cultures twice a week for 3 to 4 weeks (19, 23) . The TCC were obtained from the M. leprae-reactive T-cell lines by limiting dilution (19) , and the growing clones were expanded according to the protocols described earlier (20, 26, 29 Cytotoxicity assays. Cytotoxicity of TCC against peptidepulsed monocytes/macrophages was assessed by neutral red release assay as previously described (19, 22, 23, 30 
RESULTS
Identification of TCC recognizing the 13B3 recombinant antigen. Isolation of the recombinant phage 13B3 from a Xgtll recombinant DNA expression library by using human TCC as the primary probe has been described earlier (25) . The mycobacterial T-cell epitope expressed by the recombinant phage 13B3 is interesting, since the reactive TCC 2/3D responded to the pathogenic mycobacteria M. leprae, M. tuberculosis, and Mycobacterium africanum as well as vaccine strains of M. bovis BCG but not to other cultivable mycobacterial species tested (25) . However, a further characterization of the T-cell epitope recognized by the clone 2/3D was hampered by loss of its antigen responsiveness due to extensive subculture. A later attempt to establish TCC from the same group of donors 8 years after the primary M. leprae immunization resulted in a panel of CD4+ TCC reactive with M. leprae. When tested with different M. leprae recombinant antigens, four of these TCC derived from three different donors showed a proliferative response against the antigen expressed from the recombinant phage 13B3 (Table 1 ). In agreement with earlier results, the cross-reactivity patterns of all of these four 13B3-reactive TCC suggested that the epitope recognized is specific to the pathogenic mycobacteria and M bovis BCG (Table 1) . For comparison, proliferation of a TCC (ATT55) that responded to all mycobacteria tested but not to the recombinant antigen expressed from the recombinant phage 13B3 is also shown ( Table 1) .
Characterization of the 13B3 DNA insert and identification of the T-cell-epitope-encoding reading frame. The nucleotide sequence of the 1.75-kb M leprae DNA insert in the recombinant phage 13B3 showed that the region of M leprae DNA that may be expressed as part of a fusion protein with ,-galactosidase contained only 123 nucleotides (Fig. 1) . The remaining M leprae DNA had three additional potential reading frames. To determine whether the epitope recognized by the TCC was present in the fusion protein part, the M leprae DNA corresponding to the fusion protein region in the recombinant phage 13B3 was isolated and subcloned into Xgtl 1 and was subsequently expressed in E. coli. When tested, all of the 13B3-reactive TCC recognized the recombinant antigen expressed from DNA subclone Lfus ( Table 2 ), suggesting that (Table 2) . To exactly define the amino-and carboxyl-terminal boundaries of the epitope recognized by the 13B3-reactive clones, a new series of overlapping peptides covering the relevant sequence were synthesized. These peptides were all 12-mers and represented jumps of 1 aa along the sequence of interest. The results from testing this panel of synthetic peptides for T-cell reactivity showed that TCC ATT33 and TR3 responded to peptides P12 to P16, whereas the TCC ATT43 and NHH3 responded to the peptides P13 to P16 (Table 2 ). This reactivity pattern suggested that the minimum amino acid sequence necessary for peptide recognition by the TCC ATT33 and TR3 can be defined as aa 15 to 22, whereas the minimum sequence for the clones ATT43 and NHH3 is aa 14 to 22. Hence, fine mapping of the epitope region recognized by these TCC showed heterogeneity with regard to the amino-terminal boundary of the epitope sequence.
Mapping effector functions of 13B3-reactive T cells. The 13B3-reactive TCC were also tested for effector functions in a cytotoxicity assay using peptide-pulsed monocytes as targets. TCC recognizing a given peptide in the proliferative assay were able to lyse monocytes/macrophages pulsed with the same peptide, whereas peptides not inducing proliferation were not recognized in the cytotoxicity assay (Table 3 ). This observation is interesting, as it has been shown that cytotoxic activity of T cells against macrophages presenting mycobacterial antigen is relevant for protection (1, 32 (Table 4 ). All these haplotypes also carry the DRB4*0101 gene (DRw53). In order to differentiate presentation by HLA-DRw53 from that by HLA-DR4, DR7, and DR9, the proliferative response of the TCC to the peptide P2 was assessed in the presence of an anti-HLA-DRw53 specific antibody. It was found that the anti-DRw53 specific antibody inhibited peptide-induced T-cell proliferation (Fig. 2) . In addition, mouse L cells transfected with DRA and DRB4*0101 cDNA were highly efficient in presenting peptide P2 to the TCC (Table 4) . Representation of peptide P2-reactive T cells in peripheral blood. In order to determine the ability of peptide P2 to induce proliferation among unselected T cells and its contribution to the memory T-cell repertoire, we tested PBMC and T-cell lines raised against M. leprae and M bovis BCG from the same group of five donors 8 years after immunization with M. leprae.
Four of these donors were HLA-DRw53 positive, and unselected PBMC as well as M. leprae-and M. bovis BCGinduced polyclonal T-cell lines from all these subjects proliferated in response to the peptide P2 (Table 5) . Neither PBMC nor the T-cell lines from the DRw53-negative subject showed this response. The same PBMC and T-cell lines were also tested with M. leprae, M. leprae 65-kDa HSP, and M. leprae 18 -kDa HSP peptide 38-50. All the PBMC and T-cell lines responded to M. leprae and M. leprae 65-kDa HSP (Table 5 ). In three of the four subjects, proliferation of the cells to peptide P2 was comparable to their proliferation against the whole molecule of the M. leprae 65-kDa HSP. However, the response to the M. leprae 65-kDa HSP is directed against several epitopes (23), whereas peptide P2 constitutes a single epitope. (Table 5 ). This study confirms our earlier observations that the M. leprae 18-kDa HSP peptide 38-50 is a major M. leprae-specific T-cell epitope for a small minority of people who express HLA-DR4/ Dw4 (20, 31) , whereas peptide P2 is recognized in the context of the HILA-DRw53 molecule which is expressed in people positive for all HLA-DR4 subtypes, HLA-DR7, and HLA-DR9.
DISCUSSION
In mycobacterial diseases, both protection and immunopathology are dependent on antigen-specific MHC class IIrestricted T-cell responses (33) . Identification and characterization of mycobacterial antigens with regard to epitopes and MHC restriction elements used in T-cell recognition are therefore important both to understand pathological conditions and to develop subunit vaccines. In the case of leprosy, identification of recombinant T-cell antigens with relevance to development of new vaccines and diagnostic reagents is especially important, since M. leprae cannot be grown in vitro.
Screening of mycobacterial Xgtll recombinant DNA expression libraries with antibodies made it possible to isolate several genes encoding antigens that became accessible to T-cell assays. By using this approach, important T-cell antigens, e.g., HSP, have been identified and characterized with regard to both primary structure and epitopes recognized by T cells (4, 15, 30, 31, 43) . To identify genes encoding T-cell antigens independently of antibody reactivity, we developed a strategy which allowed screening of a Xgtll M. keprae recombinant DNA library with human TCC as the primary immunological probe (25) . As previously reported, this method was used to isolate a recombinant phage, designated 13B3, which expressed a T-cell epitope from a novel M leprae protein antigen that was recognized by the M leprae-reactive TCC 2/3D (25). Interestingly, restriction enzyme analysis showed that the M leprae DNA insert in the recombinant phage 13B3 is different from the inserts in recombinant-phage clones identified by antibody probes (25) . Upon further testing of TCC 2/3D for response to a battery of mycobacterial species, it was found that the T-cell epitope recognized by this clone is present only in the vaccine strains of M bovis BCG and in pathogenic strains of M leprae and M tuberculosis but not in the nonpathogenic atypical mycobacteria. Since the T-cell epitope is restricted to vaccine strains of M bovis BCG and classical mycobacterial pathogens, we considered further characterization of the epitope was relevant to the design of subunit vaccines against tuberculosis and leprosy. The TCC 2/3D that recognized the recombinant antigen expressed from the phage clone 13B3 was established 1 year after the vaccination of healthy human volunteers with a single dose of killed M leprae (20) . Further characterization of the epitope was hampered, because the TCC 2/3D became anergic to the antigen because of extensive subculture. A second attempt to establish M leprae-reactive TCC from the same subjects was made 8 years after the immunization. Testing of these TCC with the recombinant antigen from the phage 13B3 made it possible to identify four TCC from three different subjects responding to this antigen. All of these four TCC showed reactivities to different mycobacterial antigens identical to those exhibited by the original TCC 2/3D, demonstrating (18) and bacterial (3, 37, 38) vectors have been reported.
